NuCana plc filed a Form F-1 registration statement for an initial public offering on 2025-04-24. It has amended it 2 times. It filed its final prospectus on 2025-05-07. Each fact below is quoted from the filing named with it.
What the filings say
Listing
Our ADSs are listed for trading on The Nasdaq Capital Market under the symbol NCNA.From the 424B4 filed 2025-05-07
Shares offered
Because a purchasers purchase of ADSs in this offering could otherwise result in the purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or at the election of the purchaser, 9.99%) of our outstanding ADSs immediately following consummation of this offering, we are offering to the purchasers pre-funded warrants to purchase up to 8,393,050 ADSs, or the Pre-Funded Warrants, in lieu of ADSs.From the 424B4 filed 2025-05-07
Use of proceeds
We intend to use the net proceeds of this offering, together with our existing cash and cash equivalents, to fund activities relating to the advancement of our drug discovery and development programs, and for other general corporate purposes, including, but not limited to, working capital, capital expenditures, investments, acquisitions, should we choose to pursue any, and collaborations See Use of Proceeds in this prospectus.From the 424B4 filed 2025-05-07
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2025-04-24 | Registration statement filed (foreign issuer) | F-1 |
| 2025-04-29 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-05-02 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-05-07 | Final prospectus filed: the offering is priced | 424B4 |
Tools for this story
Each opens in a new tab, filled in for NuCana plc. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.